Artiva Biotherapeutics, Inc. ARTV
- AB-201 — Breast Cancer
- AB-201 — Gastric Cancer
- AB-201 — Bladder Cancer
HER2 (6 companies · 10 programs)
Companies with an active program directed at HER2.
Vir Biotechnology, Inc. VIR
- VIR-5818 — Breast Cancer Phase 1
- VIR-5818 — Colorectal Cancer Phase 1
Zymeworks Inc. ZYME
- Ziihera — Biliary Tract Cancer Approved
- Ziihera — Gastroesophageal Adenocarcinoma NDA Submitted
Absci Corporation ABSI
- ABS-501 Preclinical
Adagene Inc. ADAG
- ADG138 Preclinical
Cogent Biosciences, Inc. COGT
- CGT4255 — Advanced Solid Tumors Phase 1